Clinical Trials Logo

HIV clinical trials

View clinical trials related to HIV.

Filter by:

NCT ID: NCT02735642 Completed - HIV Clinical Trials

High-yield HIV Testing, Facilitated Linkage to Care, and Prevention for Female Youth in Kenya

GIRLS
Start date: May 15, 2017
Phase: N/A
Study type: Interventional

Knowledge of HIV status is a first step towards accessing HIV care, treatment, and prevention services.The GIRLS study will rigorously compare two 'seek' recruitment strategies, three 'test' strategies, and two enhancements to an adaptive (SMART trial design) 'linkage' to care intervention, among young at-risk women, 15-24 years old, in Homa Bay County, western Kenya. Additionally, we will evaluate a scalable primary prevention messaging intervention to support identified HIV-negative young women in reducing HIV risk and adhering to recommended HIV re-testing recommendations. We will also conduct an economic evaluation, using cost effectiveness analyses to determine the relative utility of each seek, test, link, and prevention interventions. Lessons learned will inform Government of Kenya, and other key policymakers, implementing partners and agencies throughout sub-Saharan Africa that are exploring policies about appropriate scale up of these multiple seek, test, link, retain, and prevention strategies to realize the dream of an AIDS-free future for adolescent girls and young women.

NCT ID: NCT02733692 Completed - HIV Clinical Trials

Culturally Congruent HIV Risk Reduction App for Young Women, an Acceptability & Pilot Evaluation

Start date: July 2015
Phase: N/A
Study type: Interventional

Smartphone applications and mobile technologies offer users the potential to access critical information (e.g., proper condom use, directions to testing sites, and other sexual and reproductive health services) when it is needed most. Relevant findings will identify areas where existing interventions may be leveraged and adapted to work among young women of color in an urban setting and their networks. As SRH smartphone apps continue to proliferate, this study will expand researchers', developers', and health educators' limited knowledge about the feasibility, acceptability and preliminary efficacy of a sexual health educational app tailored with and for young Black and Latino women, aged 18-25 in NYC, including whether this app acts as a gateway to sexual health educators, clinical and other service providers. If proven effective, findings from this study will identify areas where existing interventions may be leveraged and adapted to work among a YBLW and their networks, and potentially adapted for other high needs communities.

NCT ID: NCT02733003 Completed - HIV Clinical Trials

Implementation Research for Vulnerable Women in South Africa

Start date: September 2015
Phase: N/A
Study type: Interventional

This study sought to implement the Women's Health CoOp (Cooperative) (WHC) intervention into healthcare, antenatal, and substance treatment clinics in South Africa and translated this evidence-based intervention into real-world settings. Implementation, service, and patient outcomes will be evaluated through an iterative stepped wedge design.

NCT ID: NCT02732730 Completed - HIV Clinical Trials

Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study

Start date: October 12, 2016
Phase: Phase 4
Study type: Interventional

To assess the acceptance rate, adherence, acceptability, and continuation of oral pre-exposure prophylaxis (PrEP) among young southern African women.

NCT ID: NCT02729337 Completed - HIV Clinical Trials

Affecting the Epidemiology of HIV in Uganda

Start date: December 6, 2017
Phase: N/A
Study type: Interventional

The investigators propose to develop a comprehensive, text messaging-based HIV prevention program for Ugandan adolescents 18-22 years of age.

NCT ID: NCT02726607 Completed - HIV Clinical Trials

Adapting the HITSystem to Support Prevention of Mother-to-child HIV Transmission

Start date: August 15, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to modify the HITSystem to engage and retain HIV+ pregnant women before, during and after delivery and evaluate the HITSystem impact on prevention of mother-to-child transmission (PMTCT) related behaviors and outcomes. HITSystem 2.0 intervention will support a range of PMTCT outcomes including retention in care, ART adherence, and integration of maternal and pediatric HIV services in low-resource settings.

NCT ID: NCT02724852 Completed - HIV Clinical Trials

MMR Vaccination Among HIV-infected Adults

Start date: July 2011
Phase: Phase 4
Study type: Interventional

This is a prevalence study of protective antibodies to measles, mumps, and rubella (MMR) in HIV-infected adults and HIV-uninfected controls. MMR vaccination were provided to both groups who had no protective antibodies to at least one of the three viruses.

NCT ID: NCT02722421 Completed - HIV Clinical Trials

Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected Women

Start date: April 6, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether increasing the dose of the levonorgestrel subdermal contraceptive implant will overcome a detrimental drug-drug interaction with efavirenz based antiretroviral therapy.

NCT ID: NCT02722343 Completed - HIV Clinical Trials

Exploratory Pharmacodynamic Study of Tenofovir-Based Products

Start date: April 2016
Phase: Phase 1
Study type: Interventional

This single site study is designed to describe and measure the efficacy of oral versus vaginal dosing of TFV-based products, specifically emtricitabine/tenofovir disoproxil fumarate oral tablets (Truvada) vs tenofovir intravaginal rings (IVR).

NCT ID: NCT02720237 Completed - HIV Clinical Trials

Reducing Hazardous Alcohol Use & Human Immunodeficiency Virus (HIV) Viral Load

REDART
Start date: March 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effectiveness of two interventions [a Brief Intervention (BI) and a Motivational Enhancement Therapy+Cognitive Behavioral Therapy (MET+CBT) Intervention], against each other and with an assessment-only control, in improving both alcohol- and HIV-related outcomes, among hazardous and heavy drinking HIV-infected antiretroviral therapy (ART) clinic clients in Thai Nguyen, Vietnam.